Century Therapeutics(IPSC) - 2025 Q2 - Quarterly Results

Exhibit 99.1 PHILADELPHIA, Aug. 14, 2025 -- Century Therapeutics, Inc. ('Century', NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today reported financial results for the second quarter ended June 30, 2025, and provided a business update. "In the first half of 2025, we made important business decisions to ensure our capital resource allocation and pipeline development activities are centered on poten ...